PLUS THERAPEUTICS, INC.
PSTVOther · Non-accelerated filer<br>Smaller reporting company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $5.2M | $5.8M | $4.9M | — | — | — |
| Operating income | −$15.3M | −$14.7M | −$13.3M | −$19.7M | −$12.5M | −$9.6M |
| Net income | −$22.4M | −$13.0M | −$13.3M | −$20.3M | −$13.4M | −$8.2M |
| Total assets | $16.3M | $6.6M | $11.4M | $23.9M | $22.0M | $12.1M |
| Total liabilities | $12.3M | $15.6M | $12.7M | $17.4M | $11.1M | $9.1M |
| Equity | $4.0M | −$8.9M | −$1.3M | $6.4M | $10.8M | $3.0M |
| EPS (diluted) | $-0.29 | $-2.34 | $-4.24 | $-11.58 | $-1.11 | — |
| Shares out. | 17.0M | 4.3M | 35.1M | 22.2M | 21.1M | 3.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −293.5%
- Net margin
- −429.4%
- Return on equity
- −560.2%
- Return on assets
- −137.1%
- Return on capital (ROCE)
- −381.4%
- Liabilities / assets
- 75.5%
- Debt / equity
- 3.09×
- Book value / share
- $0.24
- Revenue growth (YoY)
- −10.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -107.82distress
- Accruals / assets
- −9.9%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2019
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Cvi Investments, Inc.Passive (13G)May 15, 2026
- Highbridge Capital Management LlcPassive (13G)May 15, 2026
- S.H.N. Financial Investments Ltd.Passive (13G)Aug 14, 2025
- Hirschman OrinPassive (13G)Jul 29, 2025
- Hewlett Fund LpPassive (13G)Jun 25, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.2M | 9.2 | -5.7% |
| Apr 30, 2026 | 1.2M | 4.4 | -8.5% |
| Apr 15, 2026 | 1.3M | 1.5 | -94.4% |
| Mar 31, 2026 | 23.9M | 4.7 | +19.0% |
| Mar 13, 2026 | 20.1M | 4.9 | -0.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 15, 2026
- Results of operationsMay 15, 2026
- Other material eventApr 21, 2026
- Director / officer changeApr 9, 2026
- Other material eventApr 8, 2026
- Modified shareholder rights · Amended charter or bylaws · Other material eventApr 2, 2026
- Director / officer changeMar 26, 2026
- Item 5.08 · Other material eventMar 12, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.